California Public Employees Retirement System’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-246,995
Closed -$3.53M 1226
2022
Q4
$3.53M Sell
246,995
-9,118
-4% -$144K ﹤0.01% 1157
2022
Q3
$6.54M Buy
256,113
+33,621
+15% +$844K 0.01% 1037
2022
Q2
$6.32M Buy
222,492
+1,550
+0.7% +$49.1K 0.01% 1023
2022
Q1
$7.79M Buy
220,942
+5,106
+2% +$171K 0.01% 1036
2021
Q4
$9.04M Buy
215,836
+107,131
+99% +$4.34M 0.01% 1021
2021
Q3
$5.33M Buy
+108,705
New +$5.3M ﹤0.01% 1187

Other funds holding MRVI

California Public Employees Retirement System's MRVI Position: Q1 2023 in Review

California Public Employees Retirement System sold out of Maravai LifeSciences (MRVI) in Q1 2023, closing a stake of 246,995 shares — an estimated $3.53M sold.

California Public Employees Retirement System first reported a position in MRVI in Q3 2021 and held it in 6 quarters. The position peaked at $9.04M in Q4 2021. 220 funds tracked by Wall St. Rank hold MRVI as of Q1 2023.

  • California Public Employees Retirement System reported no remaining Maravai LifeSciences position as of Q1 2023 after selling out during the quarter.
  • California Public Employees Retirement System sold 246,995 Maravai LifeSciences shares in Q1 2023, an estimated $3.53M.
  • California Public Employees Retirement System first reported a position in Maravai LifeSciences in Q3 2021 and held it in 6 quarters.
  • California Public Employees Retirement System's Maravai LifeSciences position peaked at $9.04M in Q4 2021.
  • 220 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2023.

Based on California Public Employees Retirement System's 13F filing for Q1 2023, filed 12 May 2023.